Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svetlana Marx

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Thrombosis and Haemostasis|July 28, 2012
Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?Job Harenberg, Svetlana Marx, Martin Wehling
British Journal of Pharmacology|July 12, 2011
New anticoagulants - promising and failed developmentsJob Harenberg, Svetlana Marx, Martin Krejczy, et al.
Expert Review of Hematology|January 26, 2012
Determination of the anticoagulant effects of new oral anticoagulants: an unmet needJob Harenberg, Svetlana Marx, Sandra Erdle, et al.
Seminars in Thrombosis and Hemostasis|March 17, 2012
Determination of rivaroxaban in human plasma samplesJob Harenberg, Sandra Erdle, Svetlana Marx, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
Determination of dabigatran in human plasma samplesJob Harenberg, Christina Giese, Svetlana Marx, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 12, 2011
Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxabanJob Harenberg, Svetlana Marx, Roland Krämer, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2011
Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variabilityJob Harenberg, Roland Krämer, Christina Giese, et al.
Journal of Thrombosis and Thrombolysis|November 14, 2013
Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countriesMartin Krejczy, Job Harenberg, Svetlana Marx, et al.
Thrombosis and Haemostasis|September 28, 2012
Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgeryJob Harenberg, Svetlana Marx, Ola E Dahl, et al.
Annals of Surgery|November 14, 2013
Laparoscopic Heller myotomy versus endoscopic balloon dilatation for the treatment of achalasia: a network meta-analysisMarkus B Schoenberg, Svetlana Marx, Jan F Kersten, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Thrombosis and Haemostasis|July 28, 2012
Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?Job Harenberg, Svetlana Marx, Martin Wehling
British Journal of Pharmacology|July 12, 2011
New anticoagulants - promising and failed developmentsJob Harenberg, Svetlana Marx, Martin Krejczy, et al.
Expert Review of Hematology|January 26, 2012
Determination of the anticoagulant effects of new oral anticoagulants: an unmet needJob Harenberg, Svetlana Marx, Sandra Erdle, et al.
Seminars in Thrombosis and Hemostasis|March 17, 2012
Determination of rivaroxaban in human plasma samplesJob Harenberg, Sandra Erdle, Svetlana Marx, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
Determination of dabigatran in human plasma samplesJob Harenberg, Christina Giese, Svetlana Marx, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 12, 2011
Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxabanJob Harenberg, Svetlana Marx, Roland Krämer, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2011
Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variabilityJob Harenberg, Roland Krämer, Christina Giese, et al.
Journal of Thrombosis and Thrombolysis|November 14, 2013
Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countriesMartin Krejczy, Job Harenberg, Svetlana Marx, et al.
Thrombosis and Haemostasis|September 28, 2012
Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgeryJob Harenberg, Svetlana Marx, Ola E Dahl, et al.
Annals of Surgery|November 14, 2013
Laparoscopic Heller myotomy versus endoscopic balloon dilatation for the treatment of achalasia: a network meta-analysisMarkus B Schoenberg, Svetlana Marx, Jan F Kersten, et al.
Pageof 1